Drug Approval | November 04, 2023
Lupin receives tentative approval from USFDA for Selexipag for injection
This product will be manufactured at Lupin's Nagpur facility in India
This product will be manufactured at Lupin's Nagpur facility in India
New Molecular biology lab launched, AIIA increased its work scope in form of MoUs
Approval of oral, once-daily VELSIPITY based on favorable safety and efficacy data from the ELEVATE UC Phase 3 trials
New effective carrier systems for drug delivery in different dosage applications including oral, topical & parenteral
Glenmark's Zita portfolio of medicines have been benefiting around 1.75 million Type 2 diabetic patients annually
He will be responsible for leading all the activities related to the Research & Development (Formulations) Division of the company
Venus Remedies' oncology wing has also secured marketing authorisation from Myanmar for another chemotherapy drug
Animations, colors, and shapes help to improve poor situational awareness, which is responsible for 81.5% of anesthesia-related errors
Two-year partnership focused on advocacy, education, and raising awareness of stroke as a global healthcare challenge
NRT offers 50% higher success rate in quitting smoking compared to unassisted attempts
Subscribe To Our Newsletter & Stay Updated
